News | May 17, 2024
Biocon posts Q4 FY24 PAT at Rs. 135 Cr
EBITDA for the quarter stood at Rs 964 crore, representing an EBITDA margin of 24%
EBITDA for the quarter stood at Rs 964 crore, representing an EBITDA margin of 24%
More than 10,000 scientific publications containing EUDRAGIT
India has reached to nearly 6,000 bio-startups from 50 in the past 10 years
Commercialization of rPEG lipids designed to improve immunogenicity profile for nucleic acid delivery
Combines biocompatibility, heat-resistance, transparency and durability
The LyondellBasell CirculenRenew polymers are made from renewable feedstocks derived from bio-based wastes
The new ECO grade is made using renewable feedstock
Three block copolymers added to RESOMER portfolio of bioabsorbable polymers
Diofan Ultra736 provides ultra-high water vapor barrier with excellent thermoformability, unlocking the potential to design thinner and more sustainable blister films
Fillauer recently announced the launch of the first-ever bio-attributed prosthetic foot shell
Subscribe To Our Newsletter & Stay Updated
